Detalles de la búsqueda
1.
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy.
Br J Cancer
; 130(7): 1109-1118, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38341511
2.
Noninvasive Artificial Intelligence System for Early Predicting Residual Cancer Burden during Neoadjuvant Chemotherapy in Breast Cancer.
Ann Surg
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557792
3.
Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer.
Cancer Immunol Immunother
; 72(3): 679-695, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36040519
4.
Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer.
Ann Surg Oncol
; 28(9): 5059-5070, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33534046
5.
Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-Hedgehog pathway.
Exp Mol Pathol
; 116: 104492, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32668286
6.
Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy.
Jpn J Clin Oncol
; 49(1): 22-28, 2019 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30508184
7.
Treatment and Outcome of 341 Papillary Breast Lesions.
World J Surg
; 43(10): 2477-2482, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209512
8.
Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study.
Chin J Cancer Res
; 28(6): 561-569, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28174484
9.
Comprehending the cuproptosis and cancer-immunity cycle network: delving into the immune landscape and its predictive role in breast cancer immunotherapy responses and clinical endpoints.
Front Immunol
; 15: 1344023, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38312844
10.
Short-term efficacy and safety of neoadjuvant pyrotinib plus taxanes for early HER2-positive breast cancer: a single-arm exploratory phase II trial.
Gland Surg
; 13(3): 374-382, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601287
11.
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer.
Breast Cancer Res Treat
; 142(3): 549-58, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24292815
12.
Nuclear transport maintenance of USP22-AR by Importin-7 promotes breast cancer progression.
Cell Death Discov
; 9(1): 211, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391429
13.
Tumor-Targeting Extracellular Vesicles Loaded with siS100A4 for Suppressing Postoperative Breast Cancer Metastasis.
Cell Mol Bioeng
; 16(2): 117-125, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37096069
14.
Multifactor artificial intelligence model assists axillary lymph node surgery in breast cancer after neoadjuvant chemotherapy: multicenter retrospective cohort study.
Int J Surg
; 109(11): 3383-3394, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830943
15.
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study.
EClinicalMedicine
; 58: 101899, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37007742
16.
Research on DCE-MRI Images Based on Deep Transfer Learning in Breast Cancer Adjuvant Curative Effect Prediction.
J Healthc Eng
; 2022: 4477099, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251566
17.
Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Breast Care (Basel)
; 17(3): 306-315, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35957948
18.
circ_0041732 Promotes Breast Cancer Progression.
Mol Cancer Res
; 20(10): 1561-1573, 2022 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35838496
19.
Dynamic changes in intrinsic subtype, immunity status, and risk score before and after neoadjuvant chemo- and HER2-targeted therapy without pCR in HER2-positive breast cancers: A cross-sectional analysis.
Medicine (Baltimore)
; 101(31): e29877, 2022 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945759
20.
Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy.
JCO Precis Oncol
; 6: e2100120, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025620